Filing Details

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. __) Under the Securities Exchange Act of 1934 Streamline Health Solutions Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 86323X106 (CUSIP Number) Melissa Dehn 305 SE Chkalov Dr., Suite 111-322 Vancouver, WA 98683 (360) 737-4153 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) 12/10/2019 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [X]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 86323X106 SCHEDULE 13D Page 2 of 10 1 Name of Reporting Person Justin J. Ferayorni IRS Identification No. of Above Person (entities only) 2 Check the Appropriate Box if a Member of a Group* (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Source of Funds WC 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization United States Citizen NUMBER OF 7 Sole Voting Power 4,342,134 SHARES BENEFICIALLY 8 Shared Voting Power -0- OWNED BY EACH REPORTING 9 Sole Dispositive Power 4,342,134 PERSON WITH 10 Shared Dispositive Power -0- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 4,342,134 12 Check Box if the Aggregate Amount in Row 11 Excludes Certain Shares [ ] 13 Percent of Class Represented by Amount in Row 11 14.2% 14 Type of Reporting Person IN CUSIP No. 86323X106 SCHEDULE 13D Page 3 of 10 1 Name of Reporting Person Tamarack Capital GP, LLC IRS Identification No. of Above Person 47-4492240 (entities only) 2 Check the Appropriate Box if a Member of a Group* (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Source of Funds WC 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware NUMBER OF 7 Sole Voting Power 4,305,882 SHARES BENEFICIALLY 8 Shared Voting Power -0- OWNED BY EACH REPORTING 9 Sole Dispositive Power 4,305,882 PERSON WITH 10 Shared Dispositive Power -0- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 4,305,882 12 Check Box if the Aggregate Amount in Row 11 Excludes Certain Shares [ ] 13 Percent of Class Represented by Amount in Row 11 14.1% 14 Type of Reporting Person HC CUSIP No. 86323X106 SCHEDULE 13D Page 4 of 10 1 Name of Reporting Person Tamarack Advisers, LP IRS Identification No. of Above Person 47-4492240 (entities only) 2 Check the Appropriate Box if a Member of a Group* (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Source of Funds WC 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware NUMBER OF 7 Sole Voting Power 4,305,882 SHARES BENEFICIALLY 8 Shared Voting Power -0- OWNED BY EACH REPORTING 9 Sole Dispositive Power 4,305,882 PERSON WITH 10 Shared Dispositive Power -0- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 4,305,882 12 Check Box if the Aggregate Amount in Row 11 Excludes Certain Shares [ ] 13 Percent of Class Represented by Amount in Row 11 14.1% 14 Type of Reporting Person IA CUSIP No. 86323X106 SCHEDULE 13D Page 5 of 10 1 Name of Reporting Person Tamarack Capital Management, LLC IRS Identification No. of Above Person 90-0292676 (entities only) 2 Check the Appropriate Box if a Member of a Group* (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Source of Funds WC 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware NUMBER OF 7 Sole Voting Power 4,305,882 SHARES BENEFICIALLY 8 Shared Voting Power -0- OWNED BY EACH REPORTING 9 Sole Dispositive Power 4,305,882 PERSON WITH 10 Shared Dispositive Power -0- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 4,305,882 12 Check Box if the Aggregate Amount in Row 11 Excludes Certain Shares [ ] 13 Percent of Class Represented by Amount in Row 11 14.1% 14 Type of Reporting Person HC CUSIP No. 86323X106 SCHEDULE 13D Page 6 of 10 1 Name of Reporting Person Tamarack Global Healthcare Fund, L.P. IRS Identification No. of Above Person 20-8297742 (entities only) 2 Check the Appropriate Box if a Member of a Group* (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Source of Funds WC 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware NUMBER OF 7 Sole Voting Power 3,598,334 SHARES BENEFICIALLY 8 Shared Voting Power -0- OWNED BY EACH REPORTING 9 Sole Dispositive Power 3,598,334 PERSON WITH 10 Shared Dispositive Power -0- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 3,598,334 12 Check Box if the Aggregate Amount in Row 11 Excludes Certain Shares [ ] 13 Percent of Class Represented by Amount in Row 11 11.8 14 Type of Reporting Person PN

CUSIP No. 86323X106 SCHEDULE 13D Page 7 of 10 Item 1. Security and Issuer This Schedule 13D ("Schedule") relates to shares of Common Stock, $0.01 par value (the "Common Stock"), of Streamline Health Solutions Inc. (the "Issuer"). The principal executive office of the Issuer is 1175 Peachtree Street NE, 10th Floor, Atlanta, GA 30361. Item 2. Identity and Background This Schedule is filed on behalf of the following entities: Justin John Ferayorni, a United States Citizen. Tamarack Capital GP, LLC, a Delaware limited liability company (?Tamarack GP?) Tamarack Advisers, LP, a Delaware limited partnership(?Tamarack IA?) Tamarack Capital Management, LLC, a Delaware limited liability company(?Tamarack PFGP?) Tamarack Global Healthcare Fund, L.P., a Delaware limited partnership(?Tamarack GHF?) The business address of the reporting entities is 5050 Avenida Encinas, Suite 360, Carlsbad, CA 92008. Mr. Ferayorni?s main occupation or employment is an investment adviser representative with Tamarack Advisers, LP, a registered investment adviser located at the address listed above. Mr. Ferayorni is the sole owner of Tamarack GP, the general partner of Tamarack IA, of which he also the sole limited partner. Mr. Ferayorni is the sole owner of Tamarack PFGP, the general partner of Tamarack GHF. Mr. Ferayorni has not, during the past five years, been convicted of any criminal proceeding (excluding traffic violations or similar misdemeanors). None of the reporting entities have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. CUSIP No. 86323X106 SCHEDULE 13D Page 8 of 10 Item 3. Source and Amount of Funds or Other Consideration Funds for the purchases of Common Stock were obtained from the working capital of Mr. Ferayorni, a number of Mr. Ferayorni?s family members, Tamarack GHF, and an additional private fund for which Tamarack PFGP serves as general partner and Tamarack IA serves as investment adviser. Item 4. Purpose of Transaction. The purchases of Common Stock were made solely for investment purposes. Depending upon market conditions and other factors, the reporting entities may increase beneficial ownership of securities of the Issuer, or alternatively, may dispose of some or all of the securities of the Issuer that it beneficially owns. Item 5. Interest in Securities of the Issuer (a),(b) Reference is made hereby to Items 7-11 and 13 of pages 2 through 6 of this Schedule, which Items are incorporated by reference herein. The calculation of percentage of beneficial ownership in item 13 of pages 2 through 8 were derived from the Issuer's Form 10-Q filed with the Securities and Exchange Commission on September 12, 2019, in which The Issuer stated that the number of shares of Common Stock outstanding as of December 31, 2005 was 20,599,003 and from the Issuer's Form 8-K filed with the Securities and Exchange Commission on October 18, 2019, in which The Issuer stated that the number of shares of Common Stock outstanding was increased by 20,599,003 shares for a total of 30,538,164 shares. (c) The reporting entities acquired beneficial ownership over the following stock in the last sixty days, as part of their regular investment activities using FINRA registered broker-dealers. Date #of shares Price ---------------- ---------------- $------------- 10/16/2019 1,840,282 1.02 10/16/2019 707,548 1.02 The above listed trades were effected by Tamarack GHF and the additional private fund for which Tamarack PFGP serves as general partner and Tamarack IA serves as investment adviser in a private transaction using Craig-Hallum Capital Group LLC as placement agent. CUSIP No. 86323X106 SCHEDULE 13D Page 9 of 10 (d) Other than the reporting persons, the additional private fund, for which Tamarack PFGP serves as general partner and Tamarack IA serves as investment adviser, and the owners of the family accounts managed by Mr. Ferayorni have the right to receive or the power to direct the receipt of dividends from, or the proceeds from, the sale of the common stock mentioned in item 1. (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer None. Item 7. Material to be Filed as Exhibits None. Signatures After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. DATED: December 11, 2019 Justin J. Ferayorni /s/ Justin J. Ferayorni ________________________ By: Justin J. Ferayorni Its: Himself Tamarack Capital GP, LLC /s/ Justin J. Ferayorni ________________________ By: Justin J. Ferayorni Its: Managing Member Tamarack Advisers, LP /s/ Justin J. Ferayorni ________________________ By: Justin J. Ferayorni Its: Managing member of its general partner Continued on next page CUSIP No. 86323X106 SCHEDULE 13D Page 10 of 10 Signatures (continued) Tamarack Capital Management, LLC /s/ Justin J. Ferayorni ________________________ By: Justin J. Ferayorni Its: Managing member Tamarack Global Healthcare Fund, L.P. /s/ Justin J. Ferayorni ________________________ By: Justin J. Ferayorni Its: Managing member of its general partner